Antibody-drug conjugates (ADCs) are a cutting-edge class of biopharmaceuticals that combine the targeting capability of monoclonal antibodies (mAbs) with the potent therapeutic effect of cytotoxic drugs. ADC manufacturing involves specialized expertise and technologies across both biological and chemical production. Here’s an overview of ADC manufacturers and their contributions:

Emerging Players

• Creative Biolabs:
  • Offers ADC development services, including antibody optimization, payload-linker design, and conjugation strategies.
  • Focus on customized solutions for research purposes.